Tel Aviv-based Ibex Medical Analytics, which uses AI for cancer diagnostics, raised a $55M Series C led by 83North, bringing its total funding to $100M+
Ibex Medical Analytics (Ibex), which develops AI-powered cancer diagnostics, announced on Wednesday that it has closed a $55 million Series C financing round led by 83North. Additional participants in the round were Sienna Venture Capital and existing investors in the company, Octopus Ventures,…#ibexmedicalanalytics #siennaventurecapital #octopusventures #amoon #israel #ibexsgalen #upmc #wales #astrazeneca #daiichisankyo (Source: Reuters: Health)
Source: Reuters: Health - September 7, 2023 Category: Consumer Health News Source Type: news
Lilly, Novo Nordisk top pharma performers in August; AstraZeneca, Roche lag
(Source: Reuters: Health)
Source: Reuters: Health - September 2, 2023 Category: Consumer Health News Source Type: news
Big Pharma ’s American Con
In response to this week’s launch of a new program letting Medicare negotiate lower prices for a handful of medicines, drugmakers are insisting the initiative will limit patients’ access to medicine and stifle the development of new cures. However, all 10 of the drugs up for negotiation are…#medicare #democrats #endpointsnews #merck #newjersey #phrma #astrazeneca #boehringeringelheim #bristolmyerssquibb #johnsonjohnson (Source: Reuters: Health)
Source: Reuters: Health - September 2, 2023 Category: Consumer Health News Source Type: news
Prayer to Cure Cancer; Exercise for Sexual Dysfunction; Carb Intake and Cancer
(MedPage Today) -- How to respond to a loved one who thinks prayer will cure cancer. (New York Times Magazine)
AstraZeneca has joined the legal fray in opposition to the federal government's plans to negotiate drug prices for Medicare.
One oncology... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - September 1, 2023 Category: Hematology Source Type: news
These Are the Shots You Should Get This Fall and Winter
It used to be relatively easy and straightforward to navigate the fall and winter respiratory disease season in the U.S.—get a flu shot. Then came COVID-19, and another vaccine was added to the mix.
Now, for the first time, there will be a third shot for some groups: a vaccine for respiratory syncytial virus (RSV), which causes respiratory disease that can be especially dangerous for infants and older people.
[time-brightcove not-tgx=”true”]
Here’s what experts say about who should be receiving which shots, and when.
Flu (the easy one)
The advice here is straightforward and the same as ...
Source: TIME: Health - August 30, 2023 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news
AstraZeneca jumps on IRA litigation bandwagon, raising concerns over'unintended consequences' in rare disease R & D
With one week to go until the Centers for Medicare and Medicaid Services (CMS) releases its list of ten drugs up for the first round of pricing negotiations, AstraZeneca is jumping into the legal b | The company cited concerns with the law's consequences for orphan drug development. AstraZeneca…#centersformedicare #medicaidservices #cms #astrazeneca #ira (Source: Reuters: Health)
Source: Reuters: Health - August 26, 2023 Category: Consumer Health News Source Type: news
AstraZeneca becomes first international company to file Medicare drug pricing suit
has joined the legal fight against Medicare drug pricing negotiations, becoming the sixth pharmaceutical company, and first international company, to file suit against US Health Secretary Xavier Becerra and CMS Administrator Chiquita Brooks-LaSure. "We made a very thoughtful decision after…#medicare #xavierbecerra #cms #chiquitabrookslasure #davidfredrickson #astrazeneca #evp #yahoofinance #fifthamendment #orphandrugact (Source: Reuters: Health)
Source: Reuters: Health - August 25, 2023 Category: Consumer Health News Source Type: news
AstraZeneca sues US over Medicare drug price negotiation plans
FILE PHOTO: FILE PHOTO: FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the NYSE in New York, United States (Reuters) -AstraZeneca said on Friday it has sued the U.S. government to block parts of a program that gives the Medicare health…#astrazeneca #medicare #delaware #johnsonjohnson #merckco #bristolmyerssquibb #boehringeringelheim #soliris #hhs (Source: Reuters: Health)
Source: Reuters: Health - August 25, 2023 Category: Consumer Health News Source Type: news
PicnicHealth partners with AstraZeneca to advance cancer datasets
The partners created a registry to generate real-world data using consenting U.S. patients ' medical records to further research in stage 1 to 3 breast cancer. (Source: mobihealthnews)
Source: mobihealthnews - August 21, 2023 Category: Information Technology Source Type: news
FDA Warns AstraZeneca on'Misleading Claims' About COPD Drug FDA Warns AstraZeneca on'Misleading Claims' About COPD Drug
Claims that Breztri has been shown to reduce risk of death in COPD patients are not supported by clinical data, the agency says.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 16, 2023 Category: Consumer Health News Tags: Pulmonary Medicine News Source Type: news
AstraZeneca Pharmaceuticals LP - 664789 - 08/04/2023
False& Misleading Claims/Misbranded (Source: FDA Center for Drug Evaluation and Research - What's New)
Source: FDA Center for Drug Evaluation and Research - What's New - August 15, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news
ISPE Announces Leaders from Health Canada, AltruBio, AstraZeneca, Gilead, Lonza, Lyndra, and More to Speak at the 2023 ISPE Annual Meeting & amp; Expo
The International Society for Pharmaceutical Engineering (ISPE) announced eight keynote speakers for the 2023 ISPE Annual Meeting & Expo, taking place 15-18 October in Las Vegas, NV. This signature event brings together top pharmaceutical industry and regulatory leaders offering... (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - August 11, 2023 Category: Pharmaceuticals Tags: TDS Source Type: news
New RSV shots could give parents peace of mind
The arrival of two shots that protect infants against respiratory syncytial virus could give parents some peace of mind from the leading cause of hospitalization of U.S. children under the age of 1. But that's only if the new treatments don't get caught up in broader vaccine skepticism — or just…#rsv #michaelchang #houston #cdc #sanofi #astrazeneca #affordablecareact #medimmune #beyfortus #sarahschafferderoo (Source: Reuters: Health)
Source: Reuters: Health - August 4, 2023 Category: Consumer Health News Source Type: news
Infants Should Get The Recently Approved RSV Vaccine This Fall, Health Officials Say
Infants should get a recently approved drug to protect them against a respiratory virus that sends tens of thousands of American children to the hospital each year, U.S. health officials said Thursday.
An infection with RSV is a coldlike nuisance for most healthy people, but it can be life-threatening for the very young and the elderly. There are no vaccines for babies yet so the new drug, a lab-made antibody that helps the immune system fight off the virus, is expected to fill a critical need.
[time-brightcove not-tgx=”true”]
The drug, developed by AstraZeneca and Sanofi, is expected to be ready in...
Source: TIME: Health - August 4, 2023 Category: Consumer Health News Authors: CARLA K. JOHNSON / AP Tags: Uncategorized Vaccines Source Type: news
CDC Panel Recommends Preventive RSV Therapy for Babies CDC Panel Recommends Preventive RSV Therapy for Babies
The US Centers for Disease Control and Prevention (CDC) said its advisory panel on Thursday recommended use of Sanofi and partner AstraZeneca ' s antibody therapy to prevent respiratory syncytial virus (RSV) in infants and toddlers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 4, 2023 Category: Consumer Health News Tags: Pediatrics News Source Type: news
